Tuesday, July 19, 2022 7:19:30 AM
Company will also begin pursuing strategic investments in complementary technologies
SANTA BARBARA, CA – July 19, 2022 – SunHydrogen, Inc. (OTC: HYSR), the developer of a breakthrough technology to produce renewable hydrogen using sunlight and water, today shared an update detailing the Company’s financial position following the completion of the 2022 fiscal year on June 30.
SunHydrogen reports a financial position of $52 million in cash and cash equivalents on its balance sheet as of June 30, 2022, a number that instills confidence in its executive and scientific teams alike as the Company continues moving toward the commercialization of its nanoparticle-based green hydrogen technology.
SunHydrogen is currently at a critical developmental juncture with the goal of a production-quality prototype set for the end of 2022.
“Being well-capitalized at this time not only allows us to feel confident about seeing our technology through to commercial viability, but it also allows us to begin exploring strategic investments in the hydrogen space,” said SunHydrogen’s CEO Tim Young.
“SunHydrogen is actively pursuing opportunities for investment and acquisition of complementary hydrogen technologies,” Mr. Young continued. “Amid the widespread market downturn, we are fortunate to have the resources to fully support our own technology and simultaneously maximize our impact in this fast-growing industry.”
The Company’s investment strategy will be led by Chief Operating Officer Woosuk Kim, who formerly served as Senior Vice President and Head of the M&A Group at Seoul-based SK Innovation. Mr. Kim has executed over $4 billion in mergers, acquisitions and joint ventures throughout his career.
SunHydrogen’s full annual report will be available in accordance with SEC regulations in September 2022.
https://www.sunhydrogen.com/news-posts/sunhydrogen-well-capitalized-for-nanoparticle-based-green-hydrogen-technologys-continued-development-toward-commercialization
Recent HYSR News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/21/2024 07:32:27 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/15/2024 09:01:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/13/2024 09:31:40 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/02/2024 05:15:09 AM
- Form DEL AM - Delaying amendment • Edgar (US Regulatory) • 01/25/2024 09:40:59 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 01/24/2024 09:32:53 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 08:28:16 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/29/2023 09:03:04 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/29/2023 08:33:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/29/2023 08:13:34 PM
North Bay Resources Reports Assays up to >25% Mg, 0.1% Ni, 0.1% Cu, 0.01% Co, 0.3 ppm Pt at Tulameen Platinum Project, British Columbia • NBRI • May 29, 2024 9:03 AM
One World Products, Inc. Issues Shareholder Update • OWPC • May 29, 2024 8:20 AM
Green Leaf Innovations, Inc. Engages Olayinka Oyebola & Co for Two-Year Audit • GRLF • May 28, 2024 8:30 AM
HealthLynked Introduces AI-Powered Chat Function to Enhance Healthcare Accessibility • HLYK • May 28, 2024 8:00 AM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM